Showing 751-760 of 964 results for "".
- New Aesthetic Society Data: Facelifts, Breast Procedures, and Body Procedures Surged in 2021https://modernaesthetics.com/news/new-aesthetic-society-data-facelifts-breast-procedures-and-body-procedures-surged-in-2021/2473217/Plastic surgery is booming, according to the Aesthetic Society’s annual
- Business News: Solta Medical Readies for IPOhttps://modernaesthetics.com/news/business-news-solta-medical-readies-for-ipo/2473195/Bausch Subsidiary Solta Medical Corporation is getting ready to go public. The Company publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering ("IPO") of Solta's common shares.
- Aesthetics Biomedical Expands Vivace and SoME Skincare Ambassadorship Programhttps://modernaesthetics.com/news/aesthetics-biomedical-expands-vivace-and-some-skincare-ambassadorship-program/2473177/Aesthetics Biomedical Inc. (ABM) has expanded its Vivace & SoME Skincare Ambassadorship Program, which brings notable plastic surgeons, dermatologists, medical aesthetic practitioners, and skincare professionals together with two fast growing aestheti
- Allergan Aesthetics Completes Soliton Acquisition, Adds Resonic to Portfoliohttps://modernaesthetics.com/news/allergan-aesthetics-completes-soliton-acquisition-adds-resonic-to-portfolio/2473176/It’s official. Allergan Aesthetics, an AbbVie company, completed its acquisition of Soliton, Inc. The addition of Soliton and its technology complements Allergan Aesthetics' portfolio of non-invasive body contouring treatments to now include the RES
- FDA Clears Sofwave for Eyebrows, Sub-Mental, and Neck Facial Areashttps://modernaesthetics.com/news/fda-clears-sofwave-for-eyebrows-sub-mental-and-neck-facial-areas/2473168/Sofwave is now U.S. Food and Drug Administration (FDA)-cleared for lifting the eyebrow and lifting lax submental tissue and neck tissue in people aged 22 or older. In addition, the Sofwave system featuring the Company's proprietary Superb TM (Synchronous Ultrasound Parallel Be
- Bausch Health Pursues IPO of Solta Medicalhttps://modernaesthetics.com/news/bausch-health-pursues-ipo-of-solta-medical/2473130/Bausch Health Companies Inc. is planning to pursue an initial public offering (IPO) of its Solta Medical business. Solta’s portfolio includes the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. The timing of the anticipated IPO, w
- Sofwave Medical Goes Public on the Tel Aviv Stock Exchange, Raises $50Mhttps://modernaesthetics.com/news/sofwave-medical-goes-public-on-the-tel-aviv-stock-exchange-raises-50m/2473109/Sofwave Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE) and raised $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. The company has developed Synchronous Ul
- Allergan to Buy Soliton and Resonic, Its Rapid Acoustic Pulse Devicehttps://modernaesthetics.com/news/allergan-to-buy-soliton/2473103/Allergan Aesthetics is set to acquire Soliton and Resonic, its Rapid Acoustic Pulse device. Resonic recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and is a non-invasive treatment for the short-term improvement in the appearance of cellulite. The acquisition o
- Sonrei Expands Offerings with Three New Sunscreenshttps://modernaesthetics.com/news/sonrei-expands-offerings-with-three-new-sunscreens/2473088/Sonrei has expanded its product line with three new offerings: Sonrei Clearly Zinq Tinted Mineral Gel Sunscreen SPF 45,
- FDA Accepts Special 510(k) Application for Modifications to Soliton's Resonichttps://modernaesthetics.com/news/fda-accepts-special510k-application-for-modifications-to-solitons-resonic/2473087/The FDA has accepted a special 510(k) application for modifications to Soliton's Resonic Rapid Acoustic Pulse (RAP) technology prior to commerical launch. Decisions usually take 15 to 20 days. Soliton submitted the application on March 31 and announced it was received on April 15.